Goh S, Moy F, Mat S, Ali S, Hoo Z, Apparoo S
Aging Clin Exp Res. 2025; 37(1):75.
PMID: 40067536
PMC: 11897072.
DOI: 10.1007/s40520-025-02961-5.
Astan S, Balta O
Geriatr Orthop Surg Rehabil. 2024; 15:21514593241280915.
PMID: 39290340
PMC: 11406653.
DOI: 10.1177/21514593241280915.
Johannesdottir F, Tedtsen T, Cooke L, Mahar S, Zhang M, Nustad J
J Bone Miner Res. 2024; 39(10):1454-1463.
PMID: 39151032
PMC: 11425704.
DOI: 10.1093/jbmr/zjae134.
Barzilay J, Buzkova P, Bielinski S, Cotch M, Kestenbaum B, Austin T
Osteoporos Int. 2024; 35(9):1595-1604.
PMID: 38913124
DOI: 10.1007/s00198-024-07152-y.
Jorgensen H, Lloret M, Lalayiannis A, Shroff R, Evenepoel P
Clin Kidney J. 2024; 17(5):sfae093.
PMID: 38817914
PMC: 11137676.
DOI: 10.1093/ckj/sfae093.
Lower microhardness along with less heterogeneous mineralization in the femoral neck of individuals with type 2 diabetes mellitus indicates higher fracture risk.
Cirovic A, Schmidt F, Vujacic M, Sihota P, Petrovic B, Zivkovic V
JBMR Plus. 2024; 8(3):ziae005.
PMID: 38741606
PMC: 11090112.
DOI: 10.1093/jbmrpl/ziae005.
Diabetes disrupts osteometric and trabecular morphometric parameters in the Zucker Diabetic Sprague-Dawley rat femur.
Ndou R, Perry V, Dlamini G
Anat Cell Biol. 2024; 57(2):294-304.
PMID: 38650480
PMC: 11184436.
DOI: 10.5115/acb.24.008.
Risk factors for hip and vertebral fractures in chronic kidney disease: the CRIC study.
Hsu S, Bansal N, Denburg M, Ginsberg C, Hoofnagle A, Isakova T
J Bone Miner Res. 2024; 39(4):433-442.
PMID: 38477777
PMC: 11262146.
DOI: 10.1093/jbmr/zjae021.
Effect of Chiglitazar and Sitagliptin on Bone Mineral Density and Body Composition in Untreated Patients with Type 2 Diabetes.
Wang Y, Zhou Y, Zhou X, Su X, Xu X, Li H
Diabetes Metab Syndr Obes. 2024; 16:4205-4214.
PMID: 38162801
PMC: 10757783.
DOI: 10.2147/DMSO.S439479.
Indole-carbohydrazide linked phenoxy-1,2,3-triazole-N-phenylacetamide derivatives as potent α-glucosidase inhibitors: design, synthesis, in vitro α-glucosidase inhibition, and computational studies.
Emadi M, Mosavizadeh-Marvest F, Asadipour A, Pourshojaei Y, Hosseini S, Mojtabavi S
BMC Chem. 2023; 17(1):56.
PMID: 37316931
PMC: 10268488.
DOI: 10.1186/s13065-023-00971-w.
The use of metformin, sulfonylurea compounds and insulin and the risk of hip fractures in diabetic patients: a systematic review and meta-analysis of observational studies.
Bahardoust M, Yarali M, Donyadideh G, Rahimi E, Naderi D, Tehrani F
BMC Musculoskelet Disord. 2023; 24(1):367.
PMID: 37161384
PMC: 10170842.
DOI: 10.1186/s12891-023-06493-9.
Association between exercise and risk of fractures in new-onset type 2 diabetes: a retrospective cohort study.
Lee S, Yoo J, Kim B, Kim K, Han K, Choi H
Arch Osteoporos. 2023; 18(1):61.
PMID: 37129630
DOI: 10.1007/s11657-023-01240-y.
Role of Advanced Glycation End-Products and Oxidative Stress in Type-2-Diabetes-Induced Bone Fragility and Implications on Fracture Risk Stratification.
Cavati G, Pirrotta F, Merlotti D, Ceccarelli E, Calabrese M, Gennari L
Antioxidants (Basel). 2023; 12(4).
PMID: 37107303
PMC: 10135862.
DOI: 10.3390/antiox12040928.
[Diagnosis and management of patients with diabetes and co-existing osteoporosis (Update 2023) : Common guideline of the Austrian Society for Bone and Mineral Research and the Austrian Diabetes Society].
Muschitz C, Kautzky-Willer A, Winhofer Y, Rauner M, Haschka J, Cejka D
Wien Klin Wochenschr. 2023; 135(Suppl 1):207-224.
PMID: 37101043
PMC: 10133052.
DOI: 10.1007/s00508-022-02118-8.
Bone Metabolism Parameters in Azerbaijani Pre and Postmenopausal Women with Diabetes.
Safarova S
Iran J Public Health. 2023; 52(2):334-339.
PMID: 37089145
PMC: 10113590.
DOI: 10.18502/ijph.v52i2.11886.
The association between total bile acid and bone mineral density among patients with type 2 diabetes.
Yang S, Li H, Gu Y, Wang Q, Dong L, Xu C
Front Endocrinol (Lausanne). 2023; 14:1153205.
PMID: 37033244
PMC: 10080120.
DOI: 10.3389/fendo.2023.1153205.
Relationship between geriatric nutritional risk index and osteoporosis in type 2 diabetes in Northern China.
Ji Y, Geng N, Niu Y, Zhao H, Fei W, Chen S
BMC Endocr Disord. 2022; 22(1):308.
PMID: 36494810
PMC: 9733244.
DOI: 10.1186/s12902-022-01215-z.
Musculoskeletal complications in patients with diabetes mellitus.
Choi J, Kim H, Song K
Korean J Intern Med. 2022; 37(6):1099-1110.
PMID: 36300322
PMC: 9666255.
DOI: 10.3904/kjim.2022.168.
Fibroblast Growth Factor 23 and Cardiovascular Risk in Diabetes Patients-Cardiologists Be Aware.
Kurpas A, Supel K, Wieczorkiewicz P, Bodalska Duleba J, Zielinska M
Metabolites. 2022; 12(6).
PMID: 35736431
PMC: 9254740.
DOI: 10.3390/metabo12060498.
3-(((1,3)-3-(()-Hydroxy(4-(trifluoromethyl)phenyl)methyl)-4-oxocyclohexyl)methyl)pentane-2,4-dione: Design and Synthesis of New Stereopure Multi-Target Antidiabetic Agent.
Sadiq A, Mahnashi M, Rashid U, Jan M, Alshahrani M, Huneif M
Molecules. 2022; 27(10).
PMID: 35630740
PMC: 9146474.
DOI: 10.3390/molecules27103265.